GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InMed Pharmaceuticals Inc (FRA:MWG0) » Definitions » Float Percentage Of Total Shares Outstanding

InMed Pharmaceuticals (FRA:MWG0) Float Percentage Of Total Shares Outstanding : 99.93% (As of Jun. 21, 2024)


View and export this data going back to 2004. Start your Free Trial

What is InMed Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, InMed Pharmaceuticals's float shares is 8.35 Mil. InMed Pharmaceuticals's total shares outstanding is 8.36 Mil. InMed Pharmaceuticals's float percentage of total shares outstanding is 99.93%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, InMed Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, InMed Pharmaceuticals's Institutional Ownership is 0.01%.

InMed Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

InMed Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=8.35/8.36
=99.93%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InMed Pharmaceuticals (FRA:MWG0) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InMed Pharmaceuticals Inc (FRA:MWG0) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
CWBR CNSP GMDAQ MBIO ARDS PXMD SCNI ELOX GLMD SLRX OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
INM:USA MWG0:Germany
Address
815 West Hastings Street, Suite 310, Vancouver, BC, CAN, V6C 1B4
Website
https://www.inmedpharma.com
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

InMed Pharmaceuticals (FRA:MWG0) Headlines

No Headlines